These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 16219899

  • 1. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG, Nikitin N, McGowan J.
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS, Sandell EP.
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan compared with dobutamine in low output patients.
    Nieminen MS.
    Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
    [Abstract] [Full Text] [Related]

  • 9. Randomized clinical trials with levosimendan.
    Mebazaa A, Barraud D, Welschbillig S.
    Am J Cardiol; 2005 Sep 19; 96(6A):74G-9G. PubMed ID: 16181826
    [Abstract] [Full Text] [Related]

  • 10. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 Sep 19; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 11. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
    Mebazaa A, Erhardt L.
    Int J Clin Pract; 2003 Jun 19; 57(5):410-6. PubMed ID: 12846347
    [Abstract] [Full Text] [Related]

  • 12. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
    Delaney A, Bradford C, McCaffrey J, Bagshaw SM, Lee R.
    Int J Cardiol; 2010 Feb 04; 138(3):281-9. PubMed ID: 18817994
    [Abstract] [Full Text] [Related]

  • 13. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
    Despas F, Trouillet C, Franchitto N, Labrunee M, Galinier M, Senard JM, Pathak A.
    Acute Card Care; 2010 Mar 04; 12(1):25-30. PubMed ID: 19929264
    [Abstract] [Full Text] [Related]

  • 14. A promising new inotrope: levosimendan.
    Fotbolcu H, Duman D.
    Anadolu Kardiyol Derg; 2010 Apr 04; 10(2):176-82. PubMed ID: 20382619
    [Abstract] [Full Text] [Related]

  • 15. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y.
    Expert Opin Pharmacother; 2007 Apr 04; 8(5):665-77. PubMed ID: 17376021
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
    Kota B, Prasad AS, Economides C, Singh BN.
    J Cardiovasc Pharmacol Ther; 2008 Dec 04; 13(4):269-78. PubMed ID: 19087950
    [Abstract] [Full Text] [Related]

  • 17. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 18. Levosimendan: current status and future prospects.
    Archan S, Toller W.
    Curr Opin Anaesthesiol; 2008 Feb 01; 21(1):78-84. PubMed ID: 18195615
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan: implications for clinicians.
    McBride BF, White CM.
    J Clin Pharmacol; 2003 Oct 01; 43(10):1071-81. PubMed ID: 14517189
    [Abstract] [Full Text] [Related]

  • 20. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F, Franco F, Cardoso JS.
    Am J Cardiol; 2005 Sep 19; 96(6A):80G-5G. PubMed ID: 16181827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.